Prevalence of pelvic floor dysfunction among obstetricians/gynecologists and factors influencing the choice of therapeutic approaches
Objective. To estimate the overall prevalence, age structure, leading syndrome of pelvic floor dysfunction (PFD) among obstetricians/gynecologists and to identify factors influencing the choice of therapeutic approaches.Dikke G.B., Apolikhina I.A., Kochev D.M., Shcherbatykh E.Yu.
Material and methods. 428 questionnaires anonymously completed by obstetricians/gynecologists were analyzed.
Results. The frequency of PFD in the examined cohort was about 58% and depended on age. The symptoms of prolapse were observed in 34.1% of the respondents, colorectal and urinary symptoms were seen in 33.6 and 34.6%, respectively; the symptoms of sexual dysfunction were in 41.6%. Moreover, only 12.5% of the respondents had objective information about PFD revealed by examinations. The physicians who took part in the survey regarded medical methods as first-line therapy, while choosing more often pelvic floor muscle training and, to a lesser extent, pessaries. 2.1% preferred surgical tactics. 46.4% ignored the early, but obvious signs of illness, by selecting none of the management options proposed in the questionnaire.
Conclusion. More than half of the physicians pay undue regard to their health, which requires that the medical opinion leaders and general public should draw attention to the discussed problem and that the knowledge and skills of obstetricians/gynecologists in the early diagnosis of PFD and its medical treatment should be enhanced in the continuing medical education system.
Keywords
pelvic floor dysfunction
prolapse
urinary incontinence
sexual dysfunction
pelvic floor muscle training
pessaries
References
1. Кочев Д.М., Дикке Г.Б. Дисфункция тазового дна до и после родов и превентивные стратегии в акушерской практике. Акушерство и гинекология. 2017; 5: 9-15. http://dx.doi.org/10.18565/aig.2017.5.9-15 [Kochev D.M., Dikke G.B. Pelvic floor dysfunction before and after childbirth and preventive strategies in obstetric practice. Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2017; (5): 9-15. (in Russian) http://dx.doi.org/10.18565/aig.2017.5.9-15]
2. Fonti Y., Giordano R., Cacciatore A., Romano M., La Rosa B. Postpartum pelvic floor changes. J. Prenat. Med. 2009; 3(4): 57-9.
3. Аполихина И.А., Дикке Г.Б., Кочев Д.М. Современная лечебно-профилактическая тактика при опущении и выпадении половых органов у женщин. Знания и практические навыки врачей. Акушерство и гинекология. 2014; 10: 104-10. [Apolikhina I.A., Dikke G.B., Kochev D.M. Current therapeutic and prophylactic tactics for women with genital descent and prolapse. Physicians’ knowledge and practical skills. Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2014; (10): 104-10. (in Russian)]
4. Vorvick L.J. Uterine prolapse. Available at: http://www.nlm.nig.gov/ Accessed 8 April 2010.
5. Hunskaar S., Burgio K., Diokno A., Herzog A.R., Hjälmås K., Lapitan M.C. Epid natur hist urinary incontinence in women. Urology. 2003;62(4, Suppl.): 16-23.
6. Awwad J., Sayegh R., Yeretzian J., Deeb ME. Prevalence, risk factors, and predictors of pelvic organ prolapse: a community-based study. Menopause. 2012; 19(11): 1235-41.
7. Ланг Т.А., Сесик М. Как описывать статистику в медицине. Руководство для авторов, редакторов и рецензентов. Пер. c англ. Леонов В.П., ред. М.: Практическая Медицина; 2011. 480с. [Lang T.A., Sesik M. How to describe statistics in medicine. A guide for authors, editors and reviewers. Trans. c eng. Leonov VP, ed. Moscow: Prakticheskaya Meditsina, 2011. 480p. (in Russian)]
8. Леонов В.П. Логистическая регрессия в медицине и биологии. Электронный ресурс. Режим доступа: http://www.biometrica.tomsk.ru/ [Leonov V.P. Logistic regression in medicine and biology. Electronic resource. Access mode: http://www.biometrica.tomsk.ru/ (in Russian)]
9. Ammari A., Tsikouras P., Dimitraki M., Liberis A., Kontomanolis E., Galazios G., Liberis V. Uterine prolapse complicating pregnancy. HJOG. 2014;13(2): 60-3.
10. Sze E.H., Hobbs G. Relation between vaginal birth and pelvic organ prolapse. Acta Obstet. Gynecol. Scand. 2009; 88(2): 200-3.
11. Bo K., Berghmans B., Morkved S., Van Kampen M., eds. Evidence-based physical therapy for the pelvic floor. Bridging science and clinical practice. Philadelphia, PA: Elsevier Health Sciences; 2007.
12. Clemons J.L., Aguilar V.C., Tillinghast T.A., Jackson N.D., Myers D.L. Risk factors associated with an unsuccessful pessary fitting trial in women with pelvic organ prolapse. Am. J. Obstet. Gynecol. 2004;190(2): 345-50.
13. Abdool Z., Thakar R., Sultan A.H., Oliver R.S. Prospective evaluation of outcome of vaginal pessaries versus surgery in women with symptomatic pelvic organ prolapse. Int. Urogynecol. J. 2011; 22(3): 273-8.
14. Handa V.L., Jones M. Do pessaries prevent the progression of pelvic organ prolapse? Int. Urogynecol. J. Pelvic Floor. Dysfunct. 2002;13(6): 349-51.
15. Fernando R.J., Thakar R., Sultan A.H., Shah S.M., Jones P.W. Effect of vaginal pessaries on symptoms associated with pelvic organ prolapse. Obstet. Gynecol. 2006; 108(1): 93-9.
Received 08.09.2017
Accepted 22.09.2017
About the Authors
Galina B. Dikke, Honored Scientist and Education Worker, MD, Professor of the Department of Obstetrics,Gynecology and Reproductive Medicine, Faculty of Advanced Training of Medical Workers, Peoples’ Friendship University of Russia.
117198, Russia, Moscow, Miklukho-Maklaya str. 8. Tel.: +74954345300. E-mail: galadikke@yandex.ru
Inna A. Apolikhina, MD, Head of the Department of Aesthetic Gynecology and Rehabilitation, National Medical Research Center for Obstetrics,
Gynecology and Perinatology named after Academician V.I. Kulakov of Ministry of Healthcare of Russian Federation; Professor of the Department of Obstetrics,
Gynecology, Perinatology and Reproduction, I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia.
117997, Russia, Moscow, Ac. Oparina str. 4. E-mail: i_apolikhina@oparina4.ru
Dmitry M. Kochev, Ph.D., General Director of CJSC Pentcroft Pharma. 129110, Russia, Moscow, Prospect Mira str. 68 bld. 2. Tel.: +74957887746. E-mail: pentcroft@mail.ru
Evgenia Yu. Shcherbatych, Ph.D., Development Director of CJSC Pentcroft Pharma.
129110, Russia, Moscow, Prospect Mira str. 68 bld. 2. Tel.: +74957887746. E-mail: pentcroft@mail.ru
For citations: Dikke G.B., Apolikhina I.A., Kochev D.M., Shcherbatykh E.Yu. Prevalence of pelvic floor dysfunction among obstetricians/gynecologists and factors influencing the choice of therapeutic approaches. Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2017; (10): 111-9. (in Russian)
https://dx.doi.org/10.18565/aig.2017.10.111-119
Similar Articles
